DivcoWest has been picked as the buyer for One Kendall Square, a prominent nine-building biotech campus in Boston’s Cambridge submarket. The 667,000-square-foot complex was valued at around $375 million at the time it went up for sale in October but it isn’t clear what DivcoWest has agreed....

The content you are trying to view is restricted for Real Estate Finance Intelligence
subscribers.

To continue reading, please log in using the login box in the upper right corner of this page,
 subscribe or take a free trial.

Subscribe

Start your Real Estate Finance Intelligence service today for full access

Subscribe

Free Trial

Not ready to subscribe?

Register today for a free trial.

Free Trial